UNM grants Pascal Biosciences option to VPREB1-targeted mAb for ALL

The University of New Mexico (Albuquerque, N.M.) granted Pascal Biosciences Inc. (TSX-V:PAS) an exclusive option to gain exclusive, worldwide rights to a preclinical pre-B lymphocyte gene 1 (VPREB1)-targeted mAb for B cell precursor acute lymphoblastic leukemia (ALL). Financial terms were undisclosed...